Jump to content


Diabetes drugs under scrutiny for possible risks

diabetes usa food and drug administration pancreas inflammation precancerous

  • Please log in to reply
2 replies to this topic

#1 Hum


    totally wAcKed

  • 63,716 posts
  • Joined: 05-October 03
  • Location: Odder Space
  • OS: Windows XP, 7

Posted 14 March 2013 - 22:46

A look at the diabetes drugs under investigation by the U.S. Food and Drug Administration over possible risks of pancreas inflammation and cellular changes in the pancreas that occur before cancer.

DRUG CLASS: GLP-1 mimickers, taken by nearly 1 million Americans.

HOW THEY WORK: Injections needed anywhere from twice a day to once a week, they make the body produce more insulin to lower blood sugar.

MAKER: Bristol-Myers Squibb Co.

CHEMICAL/BRAND NAMES: exenatide/Byetta and Bydureon

MAKER: Novo Nordisk A/S:

CHEMICAL/BRAND NAMES: liraglutide/Victoza


DRUG CLASS: DPP-4 inhibitors, taken by about 1.6 million Americans.

HOW THEY WORK: Pills taken once or twice a day, they stimulate insulin production and limit release of a hormone that raises blood sugar levels.

MAKER: Merck & Co.

CHEMICAL/BRAND NAMES: sitagliptin/Januvia, Janumet, Janumet XR, Juvisync

MAKER: Bristol-Myers Squibb Co. & AstraZeneca PLC

CHEMICAL/BRAND NAMES: saxagliptin/Onglyza and Kombiglyze

MAKER: Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals Inc.

CHEMICAL/BRAND NAMES: linagliptin/Jentadueto and Tradjenta

MAKER: Takeda Pharmaceuticals Co. Ltd.

CHEMICAL/BRAND NAMES: alogliptin/Nesina, Kazano and Oseni


#2 Growled


    Neowinian Senior

  • 41,508 posts
  • Joined: 17-December 08
  • Location: USA

Posted 15 March 2013 - 00:56

Why not just take a gun and shot us all and be done with it, instead of this slow, painful death they are afflicting on us now?

#3 DocM


    Neowinian Senior

  • 21,468 posts
  • Joined: 31-July 10
  • Location: Michigan

Posted 15 March 2013 - 05:31

Not what I use. Whew!